Eli Lilly (NY:LLY)

Immuneering (IMRX) Q3 2025 Earnings Transcript

Immuneering (IMRX) Q3 2025 Earnings Transcript ↗

November 13, 2025

The United States government has recently emerged from its longest shutdown in history, a 43-day impasse that concluded on November 12, 2025. This protracted closure plunged the nation into an...

Topics Intellectual Property

Post-Shutdown Data Deluge: Markets Brace for Economic Reckoning as US Government Reopens

November 13, 2025

Elon Musk Finds It ‘Cool’ That Eli Lilly CEO Uses Grok As One Of His Daily Advisors ↗

Topics Credit Cards Economy World Trade

November 11, 2025

Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs ↗

November 13, 2025

The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines.

These top growth stocks have plenty of room left to run.

Here Are the Top Growth Healthcare Stocks Every New Investor Should Know ↗

November 13, 2025

2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors ↗

November 13, 2025

Healthcare stocks have plenty to offer new investors.

Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.

1 Incredible Reason to Buy LLY's Stock in November ↗

November 13, 2025

Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play ↗

Topics Government World Trade

November 13, 2025

Canaccord said Viking’s obesity pipeline is worth far more than the current valuation.

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

November 12, 2025

Via StockStory

Eli Lilly Soars: A Pharmaceutical Giant's Breakout Fueled by Blockbuster Drugs and Strategic Vision

November 12, 2025

INDIANAPOLIS, IN – November 12, 2025 – Eli Lilly and Company (NYSE: LLY) is experiencing a monumental stock breakout today, sending ripples across the global financial markets. The pharmaceutical...

ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete? ↗

November 12, 2025

Mixed Signals on Wall Street: Dow Soars Amidst Government Shutdown Hopes, Tech Giants Stumble

November 12, 2025

New York, NY – November 12, 2025 – The U.S. stock market presented a landscape of diverging fortunes today, as the Dow Jones Industrial Average surged to new record highs, fueled by mounting optimism...

Dow Soars to All-Time Highs as Nation Awaits Crucial House Vote to End Government Shutdown

Topics Artificial Intelligence Economy Electric Vehicles

November 12, 2025

The Dow Jones Industrial Average (DJIA) has surged to unprecedented levels, marking new all-time highs this week, even as the nation holds its breath for a pivotal vote in the U.S. House of...

Dow Surges 400 Points Amid Broad Market Rally; Healthcare and Precious Metals Shine, Barrick Gold Signals Strength

Topics Artificial Intelligence Economy Government

November 12, 2025

New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) soared today, adding over 400 points and hitting fresh record highs as investors rotated back into value and cyclical stocks,...

Blue-chip stocks hit record highs as investors rotate toward old-economy leaders; AMD surges, gold rallies, oil slides on OPEC surplus outlook.

Topics Economy Stocks

Dow Jones Hits Record Highs, AMD Jumps: What's Moving Markets Wednesday? ↗

November 12, 2025

Via Benzinga

Topics Stocks

Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock ↗

November 12, 2025

Recursion is about to go toe-to-toe with the largest healthcare company.

Eli Lilly to drop CVS Health's drug benefit plan and move to Rightway in 2026 as Novo Nordisk cuts Wegovy prices in India to defend market share.

Topics Animal Testing Artificial Intelligence

$100 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today ↗

November 12, 2025

Via Benzinga

Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch ↗

November 12, 2025

Via Benzinga

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗

November 12, 2025

Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."

Via Benzinga

Why Metsera's Share Price Is Plummeting This Week ↗

November 12, 2025

The biotech start-up's stock had been rising rapidly in 2025.

This drugmaker's innovation engine continues to operate at full capacity.

This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy? ↗

November 12, 2025

Eli Lilly Stock Jumps Premarket On Dumping CVS Drug Plan After Wegovy Snub — Retail Calls It A Pushback Against PBM Power ↗

November 12, 2025

Lilly is reportedly shifting its 50,000 employees to Rightway, a fintech-driven pharmacy benefit manager, starting January 1.

‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios ↗

November 11, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds

November 11, 2025

Via StockStory

Topics Stocks

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 11, 2025

Via Benzinga

Three Healthcare Buys That Wall Street Loves ↗

November 11, 2025

These three healthcare stocks are outperforming most of the sector.

A new report shows the S&P 500 is now more concentrated than ever, with 20 companies making up over 50% of its value, driven by AI hype, not earnings.

These 20 Stocks Now Make Up Half Of The S&P 500—Here's Why That's Risky ↗

November 11, 2025

Via Benzinga

Topics Artificial Intelligence Stocks

Who's Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market? ↗

November 11, 2025

Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.